Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Transplantation|August 1, 1990
FK506--its influence on anti-class 1 MHC alloantibody responses to blood transfusionsD J Propper, J Woo, A W Thomson, et al.
Clinical Science (London, England : 1979)|January 1, 1991
Cyclosporin A and the humoral response to blood transfusion in the rat: definition of antigens which suppress alloantibody formationD J Propper, M C Jones, K N Stewart, et al.
Clinical Science (London, England : 1979)|February 1, 1991
Lymphocytotoxins in sera from highly sensitized multiparous dialysis patients: antibody class, relationship with the HLA and with paternal antigensD J Propper, W A Leheny, S J Urbaniak, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1991
The effect of cyclosporin administered during a third-party blood transfusion protocol on humoral immune responsesM C Jones, K N Stewart, D J Propper, et al.
Postgraduate Medical Journal|May 7, 2009
Neuroendocrine tumours of the gallbladder: three cases and a review of the literatureS Iype, T A Mirza, D J Propper, et al.
Transplantation|March 1, 1991
Reduction of sensitization induced by blood transfusion in the rat by monoclonal antibodiesM C Jones, D J Propper, B K Weber, et al.
Immunopharmacology and Immunotoxicology|August 1, 1993
Comparative effects of rapamycin, FK 506 and cyclosporine on antibody production, lymphocyte populations and immunoglobulin isotype switching in the ratA W Thomson, D J Propper, J Woo, et al.
British Journal of Cancer|November 21, 1998
A phase II study of bryostatin 1 in metastatic malignant melanomaD J Propper, V Macaulay, K J O'Byrne, et al.
British Journal of Cancer|June 6, 2000
Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazineD J Propper, J P Braybrooke, N C Levitt, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifenJ P Braybrooke, S Houlbrook, J E Crawley, et al.
Pageof 4